BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14963947)

  • 21. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    Aleman BM; Raemaekers JM; Tirelli U; Bortolus R; van 't Veer MB; Lybeert ML; Keuning JJ; Carde P; Girinsky T; van der Maazen RW; Tomsic R; Vovk M; van Hoof A; Demeestere G; Lugtenburg PJ; Thomas J; Schroyens W; De Boeck K; Baars JW; Kluin-Nelemans JC; Carrie C; Aoudjhane M; Bron D; Eghbali H; Smit WG; Meerwaldt JH; Hagenbeek A; Pinna A; Henry-Amar M;
    N Engl J Med; 2003 Jun; 348(24):2396-406. PubMed ID: 12802025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiotherapy and Hodgkin's lymphoma.
    Das P; Ha CS; Cox JD
    J Clin Oncol; 2005 Dec; 23(34):8914; author reply 8914-6. PubMed ID: 16314655
    [No Abstract]   [Full Text] [Related]  

  • 23. When kids get cancer.
    Thompson S
    RN; 2003 Jul; 66(7):29-33; quiz 34. PubMed ID: 12900995
    [No Abstract]   [Full Text] [Related]  

  • 24. [Do we have to treat non-Hodgkin's lymphomas the same as Hodgkin's disease?].
    Paunier JP
    Schweiz Med Wochenschr; 1975 Oct; 105(40):1278-81. PubMed ID: 1215906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Informed consent and patients with cancer: role of the nurse as advocate.
    Wilkinson K
    Clin J Oncol Nurs; 2012 Aug; 16(4):348-50. PubMed ID: 22842685
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hodgkin's disease in the pregnant patient.
    Fisher PM; Hancock BW
    Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):529-32. PubMed ID: 8958407
    [No Abstract]   [Full Text] [Related]  

  • 27. Substaging of stage III Hodgkin's disease.
    Farah R; Weichselbaum RR
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):277-86. PubMed ID: 2663828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hodgkin's lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Engert A; Eichenauer DA; Dreyling M;
    Ann Oncol; 2010 May; 21 Suppl 5():v168-71. PubMed ID: 20555072
    [No Abstract]   [Full Text] [Related]  

  • 29. [Primary-refractory forms of Hodgkin's lymphoma].
    Filatova LV; Tarasenkova AA; Gershanovich ML; Semiglazova TIu
    Vopr Onkol; 2012; 58(5):627-38. PubMed ID: 23600279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychological distress in survivors of Hodgkin's disease.
    Norum J; Wist E
    Support Care Cancer; 1996 May; 4(3):191-5. PubMed ID: 8739651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Results of management in Hodgkin's disease.
    Krishna A; Arya LS; Upadhyaya P
    Indian Pediatr; 1988 Aug; 25(8):744-9. PubMed ID: 3220561
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose therapy for aggressive non-Hodgkin's lymphoma.
    Pettengell R
    Br J Hosp Med; 1996 Nov 20-Dec 10; 56(10):521-4. PubMed ID: 8958405
    [No Abstract]   [Full Text] [Related]  

  • 33. State-of-the-art therapeutics: Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical aspects and primary therapy of Hodgkin's lymphomas].
    Sieber M; Tesch H; Diehl V
    Praxis (Bern 1994); 1996 Mar; 85(12):364-70. PubMed ID: 8643899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant lymphoma: a study of an outpatient cohort].
    Burla M; Egli F; Rhyner K
    Schweiz Rundsch Med Prax; 1990 Jan; 79(5):101-10. PubMed ID: 2305142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognosis of primary non-Hodgkin's lymphoma of the breast].
    Guo HY; Zhao XM; Cao JN; Hu XC; Yin JL; Hong XN; Li J
    Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):200-2. PubMed ID: 18756936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on Hodgkin's disease.
    Erickson JM
    Nurse Pract; 1994 Nov; 19(11):63-8. PubMed ID: 7838436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Malignant lymphoma].
    Shirakawa S; Tanaka I; Kita K
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1029-35. PubMed ID: 2414479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progress of radiation therapy in malignant lymphomas].
    Kaneta K; Nakazawa N; Kawabata K; Hashida J; Kawaguchi T; Yamashita T
    Gan No Rinsho; 1988 Apr; 34(5):555-64. PubMed ID: 3385921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.